Metraipolis › archive › dc_2ca6b4387c22

Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas? — Europe PMC PMID:41184667

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41184667
DOI
10.1007/s11102-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-08T19:54:32.297Z
SHA-256 of the archived text
7df88cd51d41814ba1bcb05d89c6cf963ab40d7023a9d215b41cf794abd7fe2d
Stable URL of this page
https://metraipolis.com/documento/dc_2ca6b4387c22

How to cite

Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas? — Europe PMC PMID:41184667 — Europe PMC (en), https://europepmc.org/article/MED/41184667 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ca6b4387c22 (Metraipolis archive dc_2ca6b4387c22, sha256 7df88cd51d41814ba1bcb05d89c6cf963ab40d7023a9d215b41cf794abd7fe2d)
BibTeX
@misc{dc2ca6b4387c22,
  title = {Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas? — Europe PMC PMID:41184667},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41184667},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ca6b4387c22; sha256 7df88cd51d41814ba1bcb05d89c6cf963ab40d7023a9d215b41cf794abd7fe2d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41184667. Agents can read the archived copy with the MCP tool read_document.